🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, double-blind, placebo-controlled, parallel-group study wil...
Status
Terminated
Location
Imaging End Points Clinical Research
Start Date
2017-03-29
Trial ID
NCT03114657
Treatments Being Tested
This substudy will evaluate the effect of crenezumab on the longitudinal ta...
Status
Completed
Location
Grupo Neurociencias de Antioquia
Start Date
2019-06-10
Trial ID
NCT03977584
Treatments Being Tested
This is a Phase II, randomized, double-blind, parallel-group, placebo-contr...
Status
Completed
Location
Banner Alzheimer's Institute
Start Date
2011-08-31
Trial ID
NCT01397578
This is a Phase II, randomized, double-blind, parallel-group, placebo-contr...
Status
Completed
Location
Hope Research Institute
Start Date
2011-04-30
Trial ID
NCT01343966
This Phase II, open-label extension (OLE), multicenter study will evaluate ...
Status
Completed
Location
Banner Alzheimer's Institute
Start Date
2012-12-07
Trial ID
NCT01723826
Treatments Being Tested
This randomized, placebo-controlled, double-blind, parallel-arm study will ...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2015-02-26
Trial ID
NCT02353598
Treatments Being Tested
This study consists of 2 periods: \[1\] Study Period A - evaluating the eff...
Status
Completed
Location
Fundacion Cardiomet
Start Date
2013-12-20
Trial ID
NCT01998841
Treatments Being Tested
This randomized, double-blind, placebo-controlled, parallel group study wil...
Status
Terminated
Location
Banner Alzheimer's Institute
Start Date
2016-03-22
Trial ID
NCT02670083
Treatments Being Tested
In the BN40031 OLE study, a dose of crenezumab of 60 mg/kg intravenous (IV)...
Status
Terminated
Location
Shankle Clinic
Start Date
2018-04-11
Trial ID
NCT03491150
Treatments Being Tested
To assess the relative bioavailability and tolerability of two different fo...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02427243
Treatments Being Tested